Literature DB >> 26836908

Intermittent Hypoxia-Induced Cardiovascular Remodeling Is Reversed by Normoxia in a Mouse Model of Sleep Apnea.

Anabel L Castro-Grattoni1, Roger Alvarez-Buvé1, Marta Torres2, Ramon Farré3, Josep M Montserrat4, Mireia Dalmases5, Isaac Almendros3, Ferran Barbé5, Manuel Sánchez-de-la-Torre6.   

Abstract

BACKGROUND: Intermittent hypoxia (IH) is the principal injurious factor involved in the cardiovascular morbidity and mortality associated with OSA. The gold standard for treatment is CPAP, which eliminates IH and appears to reduce cardiovascular risk. There is no experimental evidence on the reversibility of cardiovascular remodeling after IH withdrawal. The objective of the present study is to assess the reversibility of early cardiovascular structural remodeling induced by IH after resumption of normoxic breathing in a novel recovery animal model mimicking OSA treatment.
METHODS: We investigated cardiovascular remodeling in C57BL/6 mice exposed to IH for 6 weeks vs the normoxia group and its spontaneous recovery after 6 subsequent weeks under normoxia.
RESULTS: Aortic expansive remodeling was induced by IH, with intima-media thickening and without lumen perimeter changes. Elastic fiber network disorganization, fragmentation, and estrangement between the end points of disrupted fibers were increased by IH. Extracellular matrix turnover was altered, as visualized by collagen and mucoid interlaminar accumulation. Furthermore, left ventricular perivascular fibrosis was increased by IH, whereas cardiomyocytes size was unaffected. These cardiovascular remodeling events induced by IH were normalized after recovery in normoxia, mimicking CPAP treatment.
CONCLUSIONS: The early structural cardiovascular remodeling induced by IH was normalized after IH removal, revealing a novel recovery model for studying the effects of OSA treatment. Our findings suggest the clinical relevance of early detection and effective treatment of OSA in patients to prevent the natural course of cardiovascular diseases.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atherosclerosis recovery; cardiovascular disease; continuous positive airway pressure; intermittent hypoxia; obstructive sleep apnea

Mesh:

Year:  2016        PMID: 26836908     DOI: 10.1016/j.chest.2015.11.010

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  26 in total

1.  Normoxic Recovery Mimicking Treatment of Sleep Apnea Does Not Reverse Intermittent Hypoxia-Induced Bacterial Dysbiosis and Low-Grade Endotoxemia in Mice.

Authors:  Isabel Moreno-Indias; Marta Torres; Lidia Sanchez-Alcoholado; Fernando Cardona; Isaac Almendros; David Gozal; Josep M Montserrat; Maria I Queipo-Ortuño; Ramon Farré
Journal:  Sleep       Date:  2016-10-01       Impact factor: 5.849

Review 2.  Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.

Authors:  Elise Belaidi; Jessica Morand; Emmanuelle Gras; Jean-Louis Pépin; Diane Godin-Ribuot
Journal:  Pharmacol Ther       Date:  2016-08-02       Impact factor: 12.310

Review 3.  Murine models of sleep apnea: functional implications of altered macrophage polarity and epigenetic modifications in adipose and vascular tissues.

Authors:  Wojciech Trzepizur; Rene Cortese; David Gozal
Journal:  Metabolism       Date:  2017-11-16       Impact factor: 8.694

4.  Impact of obstructive sleep apnea on left ventricular mass index in men with coronary artery disease.

Authors:  Zhihua Huang; Ling Wang; Yuanhui Liu; Kaizhuang Huang; Ying Xu; Pingyan Chen; Jianfang Luo; Guang Li; Jiyan Chen
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

5.  The impact of obstructive sleep apnoea severity on cardiac structure and injury.

Authors:  Sandeep Raut; Gaurav Gupta; Rajiv Narang; Animesh Ray; R M Pandey; Atul Malhotra; Sanjeev Sinha
Journal:  Sleep Med       Date:  2020-11-05       Impact factor: 3.492

Review 6.  Comorbid obstructive sleep apnoea and chronic obstructive pulmonary disease and the risk of cardiovascular disease.

Authors:  Walter T McNicholas
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 7.  Systemic hypertension in obstructive sleep apnea.

Authors:  Carolina Lombardi; Martino F Pengo; Gianfranco Parati
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

8.  Differential effect of intermittent hypoxia and sleep fragmentation on PD-1/PD-L1 upregulation.

Authors:  Carolina Cubillos-Zapata; Isaac Almendros; Elena Díaz-García; Victor Toledano; Raquel Casitas; Raúl Galera; Eduardo López-Collazo; Ramón Farre; David Gozal; Francisco García-Rio
Journal:  Sleep       Date:  2020-05-12       Impact factor: 5.849

Review 9.  Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity.

Authors:  Abdelnaby Khalyfa; Leila Kheirandish-Gozal; David Gozal
Journal:  Respir Physiol Neurobiol       Date:  2017-07-01       Impact factor: 1.931

10.  Cell-Selective Altered Cargo Properties of Extracellular Vesicles Following In Vitro Exposures to Intermittent Hypoxia.

Authors:  David Sanz-Rubio; Abdelnaby Khalyfa; Zhuanhong Qiao; Jorge Ullate; José M Marin; Leila Kheirandish-Gozal; David Gozal
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.